Bicara Therapeutics Inc.
Q3 2025 13F Holders
Symbol
BCAX
CUSIP
055477103
Type
Equity
Class
COM
Num filings
115
Total reported value, excl. options
$790 M
Compare 2025 Q3 to
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type